Clinical Trials Logo
  1. Home
  2. Neurogenic Bladder
  3. NCT01228370

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Neurogenic Bladder Clinical Trial

Official title:
A 12-week, Open-label, Multi-center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Clinical Trial Summary

Because the bladder neck and proximal urethra contain abundant α1-adrenergic receptors, α-blockers or α1-blockers are well-known to reduce bladder neck obstruction in patients with or without neurogenic bladder.

α1-blockers seem to have a potential to reduce bladder outlet resistance during voiding in patients with neurogenic bladder.

Based on these turnouts, we designed this clinical study to evaluate the clinical effect and safety of silodosin on voiding dysfunction associated with neurogenic bladder.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01228370
Study type Interventional
Source JW Pharmaceutical
Contact
Status Completed
Phase Phase 4
Start date April 2011
Completion date January 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02978638 - Electrical Stimulation for Continence After Spinal Cord Injury N/A
Completed NCT03573726 - Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life N/A
Recruiting NCT06059066 - Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction N/A
Completed NCT01429090 - Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution Phase 1
Recruiting NCT05587101 - Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
Terminated NCT03843073 - Connected Catheter- Safety and Effectiveness Study N/A
Terminated NCT04059159 - Connected Catheter - Safety and Effectiveness Study N/A
Completed NCT05858840 - Urinary Artificial Sphincter in Children
Completed NCT05861024 - Urinary Calculi After Bladder Augmentation in Children
Completed NCT04074616 - Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation N/A
Completed NCT05683938 - GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study
Completed NCT04543552 - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Active, not recruiting NCT06247033 - Efficacies of Different Managements in Patients With Overactive Bladder With Stroke N/A
Withdrawn NCT01305681 - Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization Phase 1/Phase 2
Recruiting NCT04248322 - Qualitative Assessment of the Impact of TTNS on QOL and Participation
Recruiting NCT05301335 - Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study N/A
Recruiting NCT04924569 - Continence Care Registry
Completed NCT01716624 - Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder Phase 3
Completed NCT01297647 - Incidence of Urinary Tract Infection After Urodynamic Investigation N/A
Recruiting NCT04373512 - Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury Phase 2